ArticleInflammopharmacology2025
Veratric acid and zinc: a synergistic approach to accelerated wound healing in rats.
Article in Inflammopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Veratric acid, a naturally occurring derivative of benzoic acid present in various plants and fruits, has been reported to possess antioxidant, anti-inflammatory, antimicrobial, and antihypertensive properties. This study was designed to evaluate the effects of veratric acid (VA) and zinc (ZN) on wound healing in rats, assessing their individual (per se) and combined effects to determine the potential for synergistic healing benefits. In an experimental rat model, key variables, including wound closure rate, collagen synthesis, angiogenesis, and inflammation, were assessed in the presence or absence of VA and ZN, both individually and in combination. According to the study's findings, the combination of VA and ZN (10% + 10%) significantly enhances wound healing by promoting collagen synthesis, accelerating angiogenesis (the formation of new blood vessels), and reducing inflammation, thereby facilitating wound closure. The combination of veratric acid and zinc further amplified these effects, indicating a potential synergistic interaction between the two compounds. In the treatment groups, hydroxyproline levels and antioxidant parameters-including catalase, superoxide dismutase, nitric oxide, malondialdehyde, and glutathione-were significantly restored compared to the diseased control group, showing a recovery pattern similar to that of the standard control group. This study aims to provide the therapeutic potential of veratric acid, zinc, and combinations of both. The combination group shows more promising results as compared to their individual effects, indicating synergistic effects. Our data demonstrated a positive effect of the combination group along with the underlying mechanisms, suggesting its clinical potential for wound-healing applications.
Indexed as
Identifiers
40699409What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.